|
JP4160295B2
(ja)
*
|
2000-12-08 |
2008-10-01 |
武田薬品工業株式会社 |
３−ピリジル基を有する置換チアゾール誘導体、その製造法および用途
|
|
WO2002046186A1
(en)
*
|
2000-12-08 |
2002-06-13 |
Takeda Chemical Industries, Ltd. |
Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
|
|
US20040147561A1
(en)
*
|
2002-12-27 |
2004-07-29 |
Wenge Zhong |
Pyrid-2-one derivatives and methods of use
|
|
JP4847868B2
(ja)
*
|
2003-05-14 |
2011-12-28 |
ニューロジェネティック ファーマシューティカルズ、 インコーポレイテッド |
化合物、及び、アミロイドベータの調節におけるその使用
|
|
ES2222827B1
(es)
*
|
2003-07-30 |
2006-03-01 |
Laboratorios Del Dr. Esteve, S.A. |
Derivados de 5-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos.
|
|
CN101675928A
(zh)
*
|
2003-11-14 |
2010-03-24 |
沃泰克斯药物股份有限公司 |
可用作atp-结合弹夹转运蛋白调控剂的噻唑和噁唑
|
|
WO2005099711A1
(en)
*
|
2004-04-13 |
2005-10-27 |
Icagen, Inc. |
Polycyclic pyrimidines as potassium ion channel modulators
|
|
JP4602686B2
(ja)
*
|
2004-04-15 |
2010-12-22 |
広栄化学工業株式会社 |
２，６−ジハロゲノ−４−アリールピリジン類の製造法
|
|
EP1799659A1
(en)
|
2004-10-13 |
2007-06-27 |
PTC Therapeutics, Inc. |
Compounds for nonsense suppression, and methods for their use
|
|
MX2007004781A
(es)
*
|
2004-10-20 |
2007-05-11 |
Applied Research Systems |
Derivados de 3-arilamino piridina.
|
|
WO2006051723A1
(ja)
*
|
2004-11-09 |
2006-05-18 |
Kaneka Corporation |
１－ハロ－３－アリール－２－プロパノン類の製造法
|
|
GB0428514D0
(en)
*
|
2004-12-31 |
2005-02-09 |
Prosidion Ltd |
Compounds
|
|
BRPI0519774A2
(pt)
*
|
2005-01-19 |
2009-02-10 |
Biolipox Ab |
composto ou um sal farmaceuticamente aceitÁvel do mesmo, formulaÇço farmacÊutica, uso de um composto ou um sal farmaceuticamente aceitÁvel do mesmo, mÉtodo de tratamento de uma doenÇa em que inibiÇço da atividade de um membro da famÍlia mapeg É desejada e/ou necessÁria, produto combinado, e, processo para a preparaÇço de um composto
|
|
NZ563866A
(en)
|
2005-05-09 |
2011-03-31 |
Achillion Pharmaceuticals Inc |
Thiazole compounds and methods of use
|
|
WO2007016979A2
(en)
*
|
2005-07-29 |
2007-02-15 |
4Sc Ag |
NOVEL HETEROCYCLIC NF-κB INHIBITORS
|
|
FR2889526B1
(fr)
*
|
2005-08-04 |
2012-02-17 |
Aventis Pharma Sa |
7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
|
KR20080066938A
(ko)
*
|
2005-10-07 |
2008-07-17 |
깃세이 야쿠힌 고교 가부시키가이샤 |
질소 함유 복소환 화합물 및 그것을 함유하는 의약 조성물
|
|
TWI385169B
(zh)
|
2005-10-31 |
2013-02-11 |
Eisai R&D Man Co Ltd |
經雜環取代之吡啶衍生物及含有彼之抗真菌劑
|
|
CA2635541A1
(en)
*
|
2005-12-28 |
2007-07-12 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
|
|
BRPI0710479A2
(pt)
*
|
2006-01-18 |
2012-08-14 |
Hoffmann La Roche |
composto, processo para sua preparaÇço, composiÇço farmacÊutica, uso de um composto e mÉtodo de tratamento de doenÇa ou desosrdem metabàlica.
|
|
BRPI0706411A2
(pt)
*
|
2006-01-24 |
2011-03-29 |
Lilly Co Eli |
composto, composição farmacêutica, método de preparação de um indol ou um sal farmaceuticamente aceitável do mesmo, e, uso de um composto
|
|
EP2468727A1
(en)
|
2006-03-29 |
2012-06-27 |
F. Hoffmann-La Roche AG |
Pyridine and pyrimidine derivatives as MGLUR2 antagonists
|
|
WO2008021337A1
(en)
|
2006-08-15 |
2008-02-21 |
Wyeth |
Oxazinan-2-one derivatives useful as pr modulators
|
|
US7649007B2
(en)
|
2006-08-15 |
2010-01-19 |
Wyeth Llc |
Oxazolidine derivatives as PR modulators
|
|
WO2008021309A1
(en)
|
2006-08-15 |
2008-02-21 |
Wyeth |
Imidazolidin-2-one derivatives useful as pr modulators
|
|
US7618989B2
(en)
|
2006-08-15 |
2009-11-17 |
Wyeth |
Tricyclic oxazolidone derivatives useful as PR modulators
|
|
ATE534642T1
(de)
*
|
2006-09-21 |
2011-12-15 |
Eisai R&D Man Co Ltd |
Durch einen heteroarylring substituiertes pyridinderivat und antipilzmittel, das dieses enthält
|
|
EP2065377B1
(en)
|
2006-09-21 |
2011-11-23 |
Eisai R&D Management Co., Ltd. |
Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
|
|
RU2009116632A
(ru)
|
2006-10-02 |
2010-11-10 |
Кортендо Инвест, Аб (Se) |
Энантиомер кетоконазола у людей
|
|
WO2008070350A2
(en)
|
2006-10-27 |
2008-06-12 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions related to wrapping of dehydrons
|
|
US9187485B2
(en)
|
2007-02-02 |
2015-11-17 |
Baylor College Of Medicine |
Methods and compositions for the treatment of cancer and related hyperproliferative disorders
|
|
US8183263B2
(en)
|
2007-05-22 |
2012-05-22 |
Achillion Pharmaceuticals, Inc. |
Heteroaryl substituted thiazoles
|
|
TWI580356B
(zh)
|
2007-08-13 |
2017-05-01 |
孟山都科技有限責任公司 |
控制植物寄生性線蟲的化合物及方法以及被覆有該化合物之種子
|
|
JP5567481B2
(ja)
|
2007-10-09 |
2014-08-06 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グルコキナーゼアクチベーターとして有用なピリジン誘導体
|
|
US8513287B2
(en)
|
2007-12-27 |
2013-08-20 |
Eisai R&D Management Co., Ltd. |
Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
|
|
MX2010007604A
(es)
|
2008-01-11 |
2010-08-02 |
Novartis Ag |
Pirimidinas como inhibidores de cinasa.
|
|
JP5581219B2
(ja)
|
2008-01-25 |
2014-08-27 |
ミレニアム ファーマシューティカルズ， インコーポレイテッド |
チオフェンおよびホスファチジルイノシトール３−キナーゼ（ｐｉ３ｋ）阻害薬としてのその使用
|
|
CN101965176B
(zh)
|
2008-02-08 |
2012-06-20 |
株式会社资生堂 |
美白剂和皮肤外用剂
|
|
US9447049B2
(en)
|
2010-03-01 |
2016-09-20 |
University Of Tennessee Research Foundation |
Compounds for treatment of cancer
|
|
US9029408B2
(en)
|
2008-06-16 |
2015-05-12 |
Gtx, Inc. |
Compounds for treatment of cancer
|
|
US8822513B2
(en)
|
2010-03-01 |
2014-09-02 |
Gtx, Inc. |
Compounds for treatment of cancer
|
|
AU2009330686B2
(en)
*
|
2008-06-16 |
2014-07-03 |
The Ohio State University Research Foundation |
Compounds for the treatment of cancer
|
|
TWI409265B
(zh)
*
|
2008-08-20 |
2013-09-21 |
Merck Sharp & Dohme |
經取代之吡啶及嘧啶衍生物及彼等於治療病毒感染之用途
|
|
US8536185B2
(en)
|
2008-09-22 |
2013-09-17 |
Cayman Chemical Company, Incorporated |
Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases
|
|
US9090601B2
(en)
|
2009-01-30 |
2015-07-28 |
Millennium Pharmaceuticals, Inc. |
Thiazole derivatives
|
|
WO2010090716A1
(en)
|
2009-01-30 |
2010-08-12 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and their use as pi3k inhibitors
|
|
US8796314B2
(en)
|
2009-01-30 |
2014-08-05 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
KR20110128942A
(ko)
*
|
2009-03-19 |
2011-11-30 |
사노피 |
Ｈｓｐ９０ 억제 인다졸 유도체, 그를 함유하는 조성물 및 그의 용도
|
|
JP5728487B2
(ja)
*
|
2009-10-29 |
2015-06-03 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
三環式ヘテロ環化合物
|
|
WO2011051198A2
(de)
*
|
2009-10-30 |
2011-05-05 |
Bayer Cropscience Ag |
Pyridin-derivate als pflanzenschutzmittel
|
|
DE102009058280A1
(de)
|
2009-12-14 |
2011-06-16 |
Merck Patent Gmbh |
Thiazolderivate
|
|
MX2012010115A
(es)
|
2010-03-01 |
2013-02-26 |
Gtx Inc |
Compuestos para el tratamiento de cancer.
|
|
CN103140490A
(zh)
|
2010-07-15 |
2013-06-05 |
百时美施贵宝公司 |
氮杂吲唑化合物
|
|
KR101823275B1
(ko)
|
2010-08-04 |
2018-03-08 |
펠피큐어 파마슈티걸즈 아이엔씨 |
전립선 암종의 치료를 위한 병용 요법
|
|
MX2013001660A
(es)
|
2010-08-11 |
2013-06-03 |
Millenium Pharmaceuticals Inc |
Heteroarilos y usos de los mismos.
|
|
US8859768B2
(en)
|
2010-08-11 |
2014-10-14 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
WO2012021611A1
(en)
|
2010-08-11 |
2012-02-16 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
TW201307309A
(zh)
|
2010-10-13 |
2013-02-16 |
Millennium Pharm Inc |
雜芳基化合物及其用途
|
|
WO2012052412A1
(de)
*
|
2010-10-22 |
2012-04-26 |
Bayer Cropscience Ag |
Neue heterocylische verbindungen als schädlingsbekämpfungsmittel
|
|
US9056855B2
(en)
*
|
2010-10-28 |
2015-06-16 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitor compounds
|
|
US9266880B2
(en)
|
2010-11-12 |
2016-02-23 |
Bristol-Myers Squibb Company |
Substituted azaindazole compounds
|
|
GB2485404A
(en)
*
|
2010-11-15 |
2012-05-16 |
Nat Univ Ireland |
Metal-complexed pyridyl-substituted tetrazole compounds and their use in treating cancer
|
|
CN102675286B
(zh)
*
|
2011-03-07 |
2015-08-19 |
中国科学院上海药物研究所 |
一类吲唑类化合物及其制备方法、用途和药物组合物
|
|
AU2012249421B9
(en)
|
2011-04-28 |
2015-10-22 |
Novartis Ag |
17alpha-hydroxylase/C17,20-lyase inhibitors
|
|
US20120302573A1
(en)
*
|
2011-05-25 |
2012-11-29 |
Paul Francis Jackson |
Methods of inhibiting pro matrix metalloproteinase activation
|
|
US8969586B2
(en)
|
2011-09-27 |
2015-03-03 |
Bristol-Myers Squibb Company |
Substituted bicyclic heteroaryl compounds
|
|
EP2903615B1
(en)
*
|
2012-10-05 |
2021-04-07 |
Merck Sharp & Dohme Corp. |
5-pyridin-3-yl-2,3-dihydro-1h-indole derivatives as aldosterone synthase (cyp11b2) inhibitors for the treatment of hypertension
|
|
EP2934144B1
(en)
|
2012-12-20 |
2017-07-19 |
Merck Sharp & Dohme Corp. |
Indazole compounds as aldosterone synthase inhibitors
|
|
JP6835472B2
(ja)
|
2013-03-05 |
2021-02-24 |
ユニバーシティ オブ テネシー リサーチ ファウンデーション |
癌の処置のための組成物
|
|
EP2968219B1
(en)
|
2013-03-14 |
2019-04-24 |
Pellficure Pharmaceuticals, Inc. |
Novel therapy for prostate carcinoma
|
|
EP3191087A1
(en)
|
2014-09-12 |
2017-07-19 |
Pellficure Pharmaceuticals, Inc. |
Compositions and methods for treatment of prostate carcinoma
|
|
EP3528799A1
(en)
|
2016-10-24 |
2019-08-28 |
Pellficure Pharmaceuticals, Inc. |
Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione
|
|
JP7193071B2
(ja)
*
|
2017-02-08 |
2022-12-20 |
国立大学法人東海国立大学機構 |
蛍光発光材料および紫外線吸収剤
|
|
WO2021126779A1
(en)
*
|
2019-12-18 |
2021-06-24 |
The Regents Of The University Of California |
Inhibitors of lin28 and methods of use thereof
|
|
US20210246109A1
(en)
*
|
2020-02-11 |
2021-08-12 |
University Of Kentucky Research Foundation |
Potent and selective inhibitors of cytochrome p450
|
|
WO2023049199A1
(en)
*
|
2021-09-24 |
2023-03-30 |
Zeno Management, Inc. |
Azole compounds
|
|
CN117551029A
(zh)
*
|
2023-11-22 |
2024-02-13 |
河南大学 |
一种4-溴-3-氰基吡啶的合成方法
|